# Devicare, SL

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/devicare-sl

- Industry: Medical Devices & Equipment
- Headquarters: Barcelona, Spain
- Website: www.devicare.com
- Total disclosed funding: $3M
- Latest round: Series A (Jan 7, 2021)
- Investors on record: 4

## About

Devicare, SL is a healthcare company focused on developing innovative solutions for kidney health and urinary tract conditions. Their products are designed to improve patient outcomes through effective management of related health issues.Founded in 2012 and headquartered in Barcelona, Spain, Devicare, SL specializes in health solutions for kidney and urinary tract health. The company has secured a total of 7 deals, most recently raising USD 3.000 mn in Series A funding on January 7, 2021, led by Advanced MedTech Holdings, with participation from EMESA SL, Equity4Good, and the European Investment Fund. The founder, Rosendo Garganta, has a history in health-focused entrepreneurial ventures.Devicare's core offerings include the Lit-Control® line of dietary supplements that manage kidney stone formation and facilitate post-surgical recovery, alongside urinary hygiene products like Urogelus® and Nodorin®. The company also provides online consultations with healthcare professionals for personalized guidance, reaching customers in Italy, Spain, and Türkiye.In the most recent year, Devicare reported a revenue of USD 2,730,892.40 and an EBITDA of USD 341,096.70. Their revenue model is based on direct-to-consumer sales and online consultations, with key product prices including Lit-Control® pH Balance at EUR 37.40 and Urogelus® at EUR 16.94.Devicare aims to enhance its product portfolio with new offerings aimed at further improving kidney health management, although specific release dates have yet to be announced. The company is exploring expansion into new markets, targeting regions with a high prevalence of urinary tract conditions. The recent Series A funding of USD 3.000 mn will be utilized to support these product developments and market expansions.

## Funding rounds

- Series A, Jan 7, 2021, $3M — European Investment Fund, EMESA SL, Advanced MedTech Holdings, Equity4Good

## Investors

- European Investment Fund (https://capitalatlas.ai/funds/european-investment-fund) — Series A
- EMESA SL — Series A
- Advanced MedTech Holdings — Series A
- Equity4Good — Series A